As of November 5, 2019, the updated Clinical Decision Tools (CDTs) for RNs with Additional Authorized Practice [RN(AAP)s] have been adopted by SRNA Council and will be in effect beginning December 1, 2019. As of this date, the older versions of the CDTs will no longer be in effect.
The evidence and best practice guidelines have been reviewed and incorporated into the updated CDTs with in-text sources included. The Interprofessional Advisory Group (IPAG) reviewed, revised and approved all of the CDTs. During this process, it was determined that some Pediatric and Adult CDTs could be merged to streamline the processes. Additionally, charts and tables have been added to support effective and clear messaging about pharmacology options and other information within the CDTs. Language has been updated to reflect non-binary genders, for example people of reproductive age rather than women of childbearing age, and reproductive health rather than women’s health.
While the literature review is complete and all CDTs are updated for evidence-informed best practice for RN(AAP)s to diagnose, treat and prescribe for limited common medical disorders, there are no significant practice changes and no new CDTs.
It is important RN(AAP)s review all CDTs to ensure they are informed about the latest evidence for their practice.
SRNA Practice Advisors may be contacted for answers to your practice questions by email at email@example.com or by phone 306.359.4200 or 1.800.667.9945 (toll free within Canada).
When Take-Home Naloxone (THN) kits were first introduced, RN Specialty Practices were required to support the distribution of kits to clients in a standardized way. Practice has evolved and additional health care providers are also actively distributing kits to meet increased demand. The authority for distribution is currently provided through a Saskatchewan Health Authority medical directive for RNs and other health care providers. As a result, an RN Clinical Protocol is no longer required for THN kit distribution.
Employers have the responsibility to determine the education required and processes used by RNs and other health care providers who distribute THN kits to address the needs of patients and families impacted by the opioid crisis. The goal of the program is to ensure life-saving measures are available and accessible when they are needed.
Questions? Contact a Practice Advisor by email at firstname.lastname@example.org or by phone 306.359.4200 or 1.800.667.9945 (toll free within Canada).
We have received a number of calls lately about telehealth and the ability to provide this service. Telehealth connects patients and health care providers who provide health services over the phone, computer or any other form of information and communication technologies (ICT).
Providing telehealth to a Saskatchewan resident
To provide telehealth to a Saskatchewan resident, you must be registered and hold a practicing license with the SRNA. The Registered Nurses Act, 1988 in Saskatchewan outlines the need to be registered to engage in the practice of registered nursing and to use protected titles. Information about registration can be found here.
Questions about registration can be directed to Regulatory Services by email at email@example.com or by calling 306.359.4200 or 1.800.667.9945 (toll free within Canada).
Providing telehealth to clients who are residents of another province or territory
Each province/territory and country is governed by differing legislation/regulations/bylaws. We encourage you to contact the nursing regulator in that jurisdiction before providing telehealth services to their residents.
A national discussion is currently underway to examine the delivery of telehealth services across the country. We will provide updates on this issues as further information becomes available.
For a confidential consultation about a practice issue, please contact a Practice Advisor by email at firstname.lastname@example.org or call 306.359.4200 or 1.800.667.9945 (toll free within Canada).